103 results match your criteria: "Centre National de Reference Mycoses Invasives et Antifongiques.[Affiliation]"
Fungal Genet Biol
February 2016
Molecular Microbiology Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
Cryptococcus neoformans var. neoformans (serotype D) represents about 30% of the clinical isolates in Europe and is present less frequently in the other continents. It is the prevalent etiological agent in primary cutaneous cryptococcosis as well as in cryptococcal skin lesions of disseminated cryptococcosis.
View Article and Find Full Text PDFClin Microbiol Infect
September 2016
Centre Hospitalier Universitaire APHP-Saint Louis Paris, France; Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, Paris, France; CNRS URA3012, Institut Pasteur, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
The main objective of this study was to assess the diagnostic performance of a set of three Mucorales quantitative PCR assays in a retrospective multicentre study. Mucormycosis cases were recorded thanks to the French prospective surveillance programme (RESSIF network). The day of sampling of the first histological or mycological positive specimen was defined as day 0 (D0).
View Article and Find Full Text PDFLancet
February 2016
Julius-Maximilians-University, Department of Internal Medicine II, Infectious Diseases, Würzburg, Germany. Electronic address:
Background: Isavuconazole is a novel triazole with broad-spectrum antifungal activity. The SECURE trial assessed efficacy and safety of isavuconazole versus voriconazole in patients with invasive mould disease.
Methods: This was a phase 3, double-blind, global multicentre, comparative-group study.
Ann Pathol
December 2015
Unité d'histopathologie humaine et modèles animaux, Institut Pasteur, 28, rue du Dr.-Roux, 75724 Paris, France; Université Paris Descartes, PRES Sorbonne Paris Cité, 75006 Paris, France.
Cryptococcosis is a serious infection, possibly lethal, of worldwide distribution. It mainly affects immunosuppressed patients resulting with pulmonary and/or meningeal involvements or disseminated infections. Due to the rarity of visceral and osseous infections, and to the absence of specific clinical symptoms, this diagnosis is often deferred.
View Article and Find Full Text PDFMethods Mol Biol
May 2016
Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, 25 rue du Dr. Roux, 75724, Paris cedex 15, France.
To gain more insight into the epidemiological relationships between isolates of Candida spp. obtained from various origins, several molecular typing techniques have been developed. Two methods have emerged in the 2000s as soon as enough knowledge of the Candida spp.
View Article and Find Full Text PDFAnn Rheum Dis
December 2015
Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria.
No consensus has previously been formed regarding the types and presentations of infectious pathogens to be considered as 'opportunistic infections' (OIs) within the setting of biologic therapy. We systematically reviewed published literature reporting OIs in the setting of biologic therapy for inflammatory diseases. The review sought to describe the OI definitions used within these studies and the types of OIs reported.
View Article and Find Full Text PDFJ Antimicrob Chemother
November 2015
Centre d'Infectiologie Necker Pasteur, Hôpital Universitaire Necker Enfants Malades, AP-HP, IHU Imagine, 149 rue de Sèvres, 75015 Paris, France Université Paris Descartes, Sorbonne Paris-Cité, Paris, France Institut Pasteur, Centre National de Référence Mycoses Invasives et Antifongiques, Paris, France Institut Pasteur, Unité de Mycologie Moléculaire, CNRS URA3012, Paris, France
Background: Mucormycosis incidence is increasing and is associated with a high rate of mortality. Although lipid-based formulations of amphotericin B are the recommended first-line treatment, only one prospective trial in a limited number of patients has been performed to evaluate this regimen.
Methods: Patients with proven or probable mucormycosis were included between June 2007 and March 2011.
AIDS
June 2015
aUniversité Paris Descartes, Sorbonne Paris Cité, Service des Maladies Infectieuses et Tropicales et Centre d'Infectiologie Necker Pasteur, IHU Imagine bAPHP, Unité Fonctionnelle de Thérapeutique en Immuno-Infectiologie, CHU Hôtel Dieu cUniversité Paris Descartes, EA 7327 Faculté de Médecine Site Necker, Sorbonne Paris Cité, Paris dUniversité Paris Descartes, Sorbonne Paris Cité, Service de Radiologie adulte, CHU Necker-Enfants Malades eInstitut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, Centre National de la Recherche Scientifique, Unité Recherche Associée, Paris, France. *Jade Ghosn and Karima Amazzough contributed equally to the writing of this article.
Clin Infect Dis
October 2015
AP-HP, CHU Necker-Enfants malades, Centre d'Infectiologie Necker Pasteur Université Paris Descartes, Institut Imagine Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques Centre National de la Recherche Scientifique URA3012, Paris, France.
Background: Before the advent of combination antiretroviral therapy (cART), roughly 50% of cases of invasive aspergillosis (IA) associated with human immunodeficiency virus (HIV) infection involved individuals without classical predisposing host factors, and the median survival time was <4 months after diagnosis. We examined if the situation evolved over time using the revised European Organisation for Research and Treatment of Cancer/National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC) definition and analyzed survival trends after diagnosis over 20 years.
Methods: A data review committee evaluated 342 medical records that mentioned IA in the French Hospital Database on HIV.
PLoS One
January 2016
Laboratoire de Parasitologie-Mycologie, AP-HP, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Paris, France; Université Paris-Diderot, Sorbonne Cité, Paris, France; Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses invasives et Antifongiques, Paris, France; CNRS URA3012, Paris, France.
Pneumocystis pneumonia is a severe opportunistic infection in immunocompromised patients caused by the unusual fungus Pneumocystis jirovecii. Transmission is airborne, with both immunocompromised and immunocompetent individuals acting as a reservoir for the fungus. Numerous reports of outbreaks in renal transplant units demonstrate the need for valid genotyping methods to detect transmission of a given genotype.
View Article and Find Full Text PDFJ Clin Microbiol
July 2015
Service de Maladies Infectieuses et Tropicales, Hôpital Saint Louis-APHP, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Paris, France
Despite increasing reports of human infection, data about the optimal care of Phaeoacremonium infections are missing. We report a case of an infection due to Phaeoacremonium parasiticum and Paraconiothyrium cyclothyrioides, initially localized to skin and soft tissue, in a kidney transplant patient. Despite surgical drainage and excision of the lesion and combination antifungal therapy with voriconazole and liposomal amphotericin B, a disseminated infection involving the lungs and brain developed and led to death.
View Article and Find Full Text PDFPLoS One
April 2016
Laboratoire de Parasitologie-Mycologie, Groupe hospitalier Lariboisière-Saint Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France; CNRS URA3012, Paris, France; Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, Paris, France.
Background: The Platelia Aspergillus Ag assay (Bio-Rad) is designed for detecting Aspergillus galactomannan (GM) and is widely used for diagnosing invasive aspergillosis but is hampered by variable occurrences of unreproducible positive results. Frequency and origin of these unreproducible results have not been formally studied.
Methods: Different technicians simultaneously performed four tests on 550 consecutive sera from adult patients (Test#1-Test#2 for extraction#1 and Test#3-Test#4 for extraction#2).
Clin Microbiol Infect
June 2015
Laboratoire de Parasitologie-Mycologie, AP-HP, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France; Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, Paris, France; CNRS URA3012, Paris, France.
Molecular methods are crucial for mucormycosis diagnosis because cultures are frequently negative, even if microscopy suggests the presence of hyphae in tissues. We assessed PCR/electrospray-ionization mass spectrometry (PCR/ESI-MS) for Mucorales identification in 19 unfixed tissue samples from 13 patients with proven or probable mucormycosis and compared the results with culture, quantitative real-time PCR, 16S-23S rRNA gene internal transcribed spacer region (ITS PCR) and 18S PCR sequencing. Concordance with culture identification to both genus and species levels was higher for PCR/ESI-MS than for the other techniques.
View Article and Find Full Text PDFMed Mycol
April 2015
Laboratoire de Parasitologie et de Mycologie, APHP, Hôpital Saint Louis Université Paris Diderot, Sorbonne Paris Cité CNRS URA3012 Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, Paris, France
Detection of viral and bacterial DNA in nasopharyngeal aspirates (NPAs) is now a routine practice in emergency cases of febrile pneumonia. We investigated whether Pneumocystis jirovecii DNA could also be detected in these cases by conducting retrospective screening of 324 consecutive NPAs from 324 adult patients (198 or 61% were immunocompromised) admitted with suspected pulmonary infections during the 2012 influenza epidemic season, using a real-time quantitative polymerase chain reaction (PCR) assay (PjqPCR), which targets the P. jirovecii mitochondrial large subunit ribosomal RNA gene.
View Article and Find Full Text PDFMed Mycol
May 2015
Unité de Parasitologie-Mycologie, Département de microbiologie, Hôpital Necker Enfants-Malades, Paris, France Université Paris-Descartes, Paris, France.
Bacteraemia was reported to be associated with false-positive 1→3-β-D-glucan (BG) assay results. We thus prospectively assessed the reactivity of the BG (Fungitell) in samples of 21 adults with bacteraemia: . BG was negative in all and is s therefore an unlikely cause of false positive BG in adults.
View Article and Find Full Text PDFAm J Trop Med Hyg
February 2015
Université Paris-Descartes, Centre d'Infectiologie Necker-Pasteur, IHU Imagine, Hôpital Necker-Enfants Malades, APHP, Paris, France; Fédération de Pathologie Infectieuse Oculaire, Centre de Recherche Institut de la Vision, UMR S 968 Inserm/UPMC/CHNO des Quinze-Vingts, Paris, France; Institut Pasteur, Centre National de Référence Mycoses Invasives et Antifongiques, CNRS URA3012, Paris, France; Service de Microbiologie, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris, France
A 30-year-old woman with a history of contact lens wear and exposure to swimming pool water in Thailand presented with a non-responsive, progressive corneal ulcer of the right eye. Confocal microscopy evidenced septate linear branching structures, raising suspicion of fungal keratitis. She was promptly treated with topical antibiotics and both topical and intravenous caspofungin plus voriconazole.
View Article and Find Full Text PDFScientifica (Cairo)
December 2014
Université Paris Descartes, Sorbonne Paris Cité, Centre d'Infectiologie Necker Pasteur, Institut Imagine, Hôpital Universitaire Necker-Enfants Malades, APHP, 75015 Paris, France ; Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, CNRS URA3012, 75015 Paris, France.
Invasive mold infections represent an increasing source of morbidity and mortality in solid organ transplant recipients. Whereas there is a large literature regarding invasive molds infections in hematopoietic stem cell transplants, data in solid organ transplants are scarcer. In this comprehensive review, we focused on invasive mold infection in the specific population of solid organ transplant.
View Article and Find Full Text PDFMedicine (Baltimore)
November 2014
From the Hôpital Necker-Enfants malades, Department of Infectious Diseases (L. Lelièvre, ACM, OL, FL), Assistance Publique Hôpitaux de Paris, Centre d'Infectiologie Necker-Pasteur, University Paris Descartes, Paris; CNRS URA3012 (DGH, OL), Paris; Institut Pasteur, Unité de Mycologie Moléculaire (DGH, OL), Centre National de Référence Mycoses Invasives et Antifongiques, Paris; Hôpital Necker-Enfants malades, Department of Biostatistic (HA), Assistance Publique Hôpitaux de Paris, University Paris Descartes, Paris; Hôpital Européen Georges Pompidou, Department of Plastic and Reconstructive Surgery (MH, L. Lantieri), Assistance Publique-Hôpitaux de Paris, University Paris Descartes, Paris; Hôpital Maison Blanche, Mycology-Parasitology Laboratory (DT), Centre Hospitalier Universitaire de Reims; Unité MEDyC, FRE CNRS 3481 (DT), Université de Reims Champagne Ardenne; Centre Hospitalo-Universitaire d'Amiens, Université de Picardie Jules Verne, Service de parasitologie et mycologie médicales (TC), Amiens, France. Members are listed in the Appendix.
Data on clinical, mycologic characteristics, and outcome of posttraumatic mucormycosis are scarce and often limited to case reports. From the French nationwide "RetroZygo" study, we compared posttraumatic mucormycosis cases with other forms of mucormycosis. We also reviewed reports of posttraumatic mucormycosis in the English-language literature from 1993 to 2013.
View Article and Find Full Text PDFBone Marrow Transplant
January 2015
Centre Hospitalier Universitaire (CHU) de Saint Etienne, Laboratoire de mycologie, Saint Etienne, France.
PLoS Negl Trop Dis
October 2014
Centre d'Infectiologie Necker Pasteur, Université Paris Descartes, Sorbonne Paris Cité, Institut Imagine, Hôpital Universitaire Necker-Enfants malades, APHP, Paris, France; Unité de Mycologie Moléculaire, Institut Pasteur, Centre National de Référence Mycoses Invasives et Antifongiques, Paris, France.
Background: Optimal management of eumycetoma, a severely debilitating chronic progressive fungal infection of skin, disseminating to bone and viscera, remains challenging. Especially, optimal antifungal treatment and duration are ill defined.
Methodology/principal Findings: We conducted a monocentric retrospective study of 11 imported cases of eumycetoma treated by voriconazole or posaconazole for at least 6 months.
Curr Opin Hematol
November 2014
aHematology Department, Henri Mondor Teaching Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) bParis-Est Créteil University (UPEC), Créteil cParasitology-Mycology Laboratory, Groupe hospitalier Lariboisière Saint-Louis Fernand Widal dUniversité Paris-Diderot, Sorbonne Paris Cité eInstitut Pasteur, Unité de mycologie moléculaire, CNRS URA3012, Centre National de Référence Mycoses invasives et Antifongiques, Paris, France.
Purpose Of Review: This study focuses on the epidemiology and management of mucormycosis in hematopoietic stem cell transplant patients, a life-threatening mold infection whose incidence has increased over the past decades.
Recent Findings: Mucormycosis may occur in hematopoietic stem cell transplant recipients with severe graft-versus-host disease, steroids, neutropenia, iron overload, diabetes, and malnutrition, or those who received antifungals not active against Mucorales. Its incidence in allogeneic hematopoietic stem cell transplant is around 0.
Am J Trop Med Hyg
November 2014
Université Paris Descartes, Sorbonne Paris Cité, France; Service des Maladies Infectieuses et Tropicales et Centre d'Infectiologie Necker Pasteur, Service d'Hématologie Adultes, Centre d'Etude des Déficits Immunitaires, et Service de Microbiologie, Hôpital Necker-Enfants-Malades, Assistance Publique-Hôpitaux de Paris, Paris, France; Service de Pneumologie, Hôpital Simone Veil, Eaubonne, France; Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, Centre National de la Recherche Scientifique, Unité Recherche Associée 3012, Paris, France; Laboratoire de Génétique Humaine des Maladies Infectieuses, Institut National de la Santé et de la Recherche Médicale Unité 980, Faculté Necker, Fondation IMAGINE, Université Paris Descartes, Paris, France.
Histoplasmosis caused by Histoplasma capsulatum var. duboisii is a rare disease outside central and western Africa. In Europe, all cases are imported.
View Article and Find Full Text PDFDiagn Microbiol Infect Dis
October 2014
Institut Pasteur, Unité de Mycologie Moléculaire, Centre National de Référence Mycoses Invasives et Antifongiques, Paris, France; Université Paris Diderot- Paris 7, Service de Parasitologie-Mycologie, Hôpital Saint-Louis, APHP, Créteil, France.
Isolation rates of Candida glabrata at ≤2 days were 8.9% and 34.8% at >2 days; for Cryptococcus neoformans, they were 0.
View Article and Find Full Text PDFInt J Antimicrob Agents
June 2014
Assistance Publique - Hôpitaux de Paris, Service de Médecine Interne et Immunologie Clinique, Hôpital Universitaire Bicêtre, 94275 Le Kremlin-Bicêtre Cedex, France; Université Paris Sud XI, 63 rue Gabriel Péri, 94276 Le Kremlin-Bicêtre Cedex, France.
Amphotericin B is a powerful polyene antifungal drug used for treating systemic fungal infections and is usually administered for a short period. Side effects after prolonged use are unknown in humans. Here we report the case of a 28-year-old man suffering from chronic granulomatous disease (CGD), treated for invasive cerebral aspergillosis with liposomal amphotericin B (L-AmB) for a very long time (8 consecutive years).
View Article and Find Full Text PDFPLoS One
December 2014
Inserm UMRS 1136, Paris, France; UPMC Univ Paris 06 UMRS 1136, Paris, France.
Objective: To describe characteristics and outcomes of HIV-infected patients with Pneumocystis jirovecii pneumonia (PCP) over 2004-2011 in France, in particular in those previously enrolled (PE) in the French Hospital Database on HIV (FHDH).
Methods: PE patients with an incident PCP were compared with patients with an inaugural PCP revealing HIV infection (reference). Adequate adherence to care was defined as a CD4 measurement at least every 6 months.